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Clinical reports on monozygotic and dizygotic twins provided the initial evidence for the involvement of genetic
factors in risk vulnerability for fetal alcohol spectrum disorders (FASD) including fetal alcohol syndrome (FAS).
Research with selectively bred and inbred rodents, genetic crosses of these lines and strains, and embryo culture
studies have further clariﬁed the role of both maternal and fetal genetics in the development of FASD. Research to
identify speciﬁc polymorphisms contributing to FASD is still at an early stage. To date, polymorphisms of only one
of the genes for the alcohol dehydrogenase enzyme family, the ADH1B, have been demonstrated to contribute to
FASD vulnerability. In comparison with ADH1B*1, both maternal and fetal ADH1B*2 have been shown to reduce
risk for FAS in a mixed ancestry South African population. ADH1B*3 appears to afford protection for FASD
outcomes in African-American populations. Other candidate genes should be examined with respect to FASD risk,
including those for the enzymes of serotonin metabolism, in particular the serotonin transporter. By its very nature,
alcohol teratogenesis is the expression of the interaction of genes with environment. The study of genetic factors in
FASD falls within the new ﬁeld of ecogenetics. Understanding of the array of genetic factors in FASD will be
enhanced by future genetic investigations, including case-control, family association, and linkage studies. Birth
Defects Research (Part A) 73:195–203, 2005. Published 2005 Wiley-Liss, Inc.†
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INTRODUCTION
This article reviews the current understanding of the
contribution of genetic factors in the risk for alcohol-
derived teratogenesis. Research from both animal and hu-
man studies is presented, including ﬁndings on the contri-
bution of the genetic polymorphisms of the enzymes of
alcohol metabolism. It also proposes other candidate genes
and considers how future research might deﬁne the genetic
factors underlying alcohol’s role in birth defects.
HISTORY
In 1968, Lemoine and colleagues reported ﬁndings on
common characteristic growth deﬁcits, facial features,
mental impairments, and physical abnormalities observed
within a population of 127 children of alcoholic women
(Lemoine et al., 1968). This report, however, did not cap-
ture the attention of the medical community nor appear to
impact public health attitudes on alcohol use during preg-
nancy in either Europe or the United States. Five years
later, Jones et al. (1973) reported a similar pattern of ab-
normalities seen in a group of eight unrelated children
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from three ethnic groups born to alcoholic mothers. Jones
and Smith (1973) subsequently proposed the existence of
the fetal alcohol syndrome (FAS), characterized by growth
deﬁcits, neurodevelopmental delay, and a unique pattern
of craniofacial features among prenatally alcohol-exposed
children. The National Institute on Alcohol Abuse and
Alcoholism (NIAAA), newly created in 1971, began sup-
porting laboratory-based animal studies and epidemiolog-
ical research that validated the ﬁndings on alcohol terato-
genesis and FAS.
Now, more than three decades of research have led to a
fuller understanding of FAS and the broader spectrum of
craniofacial, neuroanatomical, neurodevelopmental, and
organ abnormalities associated with prenatal exposure to
alcohol (Stratton et al., 1996; Warren and Foudin, 2001).
The identiﬁcation of alcohol-associated adverse pregnancy
outcomes that did not fully meet the diagnostic criteria for
FAS (Hanson et al., 1978; Sokol and Clarren, 1989; Samp-
son et al., 1997) led to the introduction of new terms such
as fetal alcohol effects (FAE), alcohol-related birth defects
(ARBD), and alcohol-related neurodevelopmental disorder
(ARND) to provide a nomenclature for such cases (Stratton
et al., 1996). Recently, the term fetal alcohol spectrum
disorders (FASD) has been proposed as a construct that
would encompass the full range of adverse physical and
behavioral (or neuropsychological) outcomes already iden-
tiﬁed and those yet to be identiﬁed (Barr and Streissguth,
2001).
REPORTS ON TWINS
The ﬁrst indication that genetic factors may underlie
vulnerability for prenatal alcohol-induced adverse preg-
nancy outcomes was a single case report of signiﬁcant
discordance between a dyzygotic twin pair, where only
one child in the twin pair presented with full FAS (Christ-
offel and Salafsky, 1975). In a later study involving 16
alcohol-exposed twin pairs, Streissguth and Dehaene
(1993) found concordance on diagnosis among all ﬁve
monozygotic twin pairs but discordance on diagnosis for 7
of 11 dizygotic twin pairs from their populations. How-
ever, these reports alone do not rule out the alternate
hypothesis that differences in placentation, rather than
genetic vulnerability, could have been responsible for the
differences observed in outcome (Corey et al., 1979).
FINDINGS FROM ANIMAL MODELS
Animal models have proven to have great value in many
areas of alcohol research (Tabakoff and Hoffman, 2000;
Murphy et al., 2002), including its prenatal effects
(Chernoff, 1977; Maier and West, 2001).
In one of the ﬁrst animal studies on genetics and prena-
tal alcohol risk, Chernoff (1980) performed diallelic crosses
among the CBA, C3H, and C57BL mouse strains. The
extent of teratogenesis was found to be a function of the
genetics of the mothers rather than the fetus. Malforma-
tions were greater with CBA than with C3H and C57BL
mothers, respectively. However, each maternal mouse line
achieved a different peak blood alcohol concentration
(BAC), and the order for the maximal teratogenic effects
was found to correlate with peak BAC, and with alcohol
dehydrogenase (ADH) activity.
Given the limitation of this model, subsequent studies
employed alcohol administration paradigms aimed at
achieving similar BACs across strains (Boehm et al., 1997;
Gilliam et al., 1997). Using this approach, Boehm et al.
(1997) investigated the effects of prenatal alcohol on three
animal strains (Table 1). Alcohol treatment was found to
increase fetal mortality in only two of the strains (A/J and
DBA/2J). Both the extent and pattern of alcohol-induced
malformations differed by strain. For example, the
C57BL/6J mice appeared most vulnerable for prenatal al-
cohol-induced skeletal malformations.
Strain-related differences have also been demonstrated
for behavioral outcome measures in rats. Thomas et al.
(1998, 2000) administered alcohol intragastrically to pups
in the neonatal period equivalent to the human third tri-
mester and observed increased motor activity as well as
severe motor coordination deﬁcits in the selectively bred
high-alcohol–sensitive (HAS) line, but not in the low-
alcohol–sensitive (LAS) line of animals. HAS and LAS lines
Table 1
Genetic Inﬂuence in Alcohol Teratogenesis*
Inbred
mouse strain
Treatment
(n  live litters)
Malformations
Total percent of
litter malformeda
Total percent
mortalityDigits Kidney
Skeletal
(vertebral/ribs)
C57BL/6J ETOH (20 litters) 19 (n 40) 24 (n 34) 32 (mostly vertebral) (n  35) 44% 11%
Maltose (19 litters) 0 (n 38) 0 (n 35) 7 (mostly vertebral) (n  35) 4% 11%
DBA/2J ETOH (17 litters) 0 (n 23) 0 (n 19) 10 (n  14) 19% 41%
Maltose (19 litters) 0 (n 35) 0 (n 21) 7 (n  21) 7% 21%
A/J ETOH (16 litters) 0 (n 24) 0 (n 21) 68 (ribs/vertebral) (n  19) 36% 55%
Maltose (18 litters) 0 (n 39) 0 (n 35) 4 (ribs) (n  35) 9% 36%
*Alcohol was administered to mice from the three strains by gastric intubation at a dose of 5.8 g/kg ethanol on the ninth day of gestation
and fetuses were examined on GD 18. (Boehm et al., 1997). The number of ethanol-exposed litters ranged from 16 for the A/J strain to 20
for C57BL/6J strain. The number of maltose control litters ranged from 18 for A/J strain to 19 for C57BL/6J and DBA/2J. The number of
implants was unaffected by ethanol exposure and ranged from 3.4–4.7 per mother for DBA/2J, to 8.9 for C57BL/6J, to 10.0–10.6 for the A/J.
All live fetuses were examined for gross malformations. One-half of each litter was examined for soft-tissue malformations and the other
half for skeletal malformations. Some litters had fetuses with more than one malformation and were included by the study investigators
in each category; however, they were only counted once in determining mean total values.
aBecause preparation for soft-tissue and skeletal examination could not be done on the same fetuses, it was not possible for the study
investigators to precisely determine what percentage of fetuses had both soft-tissue and skeletal malformations per litter. Therefore, the
total percentage of litter malformed values is likely to be a conservative estimate of the true malformation rates.
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are differentiated on the basis of their sensitivity to the
hypnotic effect of alcohol (Draski et al., 1992).
In a study designed to differentiate the contribution of
maternal from fetal genetic factors for teratogenesis, Gil-
liam et al. (1997) crossed two inbred strains of mice that
differed in their sensitivity for alcohol-induced birth de-
fects: the more susceptible C57BL/6J strain and the more
resistant Short Sleep (SS) strain (Fig. 1). All of the maltose-
dextrin controls exhibited a low rate of malformations,
below 4%. With prenatal alcohol exposure, the highest
malformation rate was found in the B6B6 offspring (61%).
Both the B6SS and SSB6 fetuses had lower percentages of
malformations than the highly alcohol susceptible B6B6
strain, thereby indicating a protective contribution likely
derived from the SS parent in the cross. However, the
extent of fetal malformations also differed by the genotype
of the mother: the percentage of malformations in fetuses
with a B6 mother (B6SS) was nearly nine times higher than
in fetuses with an SS mother (SSB6), as indicated by the
diagonal arrow, in Figure 1. Differences in the extent of
anomalies when maternal genotype is held constant but
paternal genotype differs (see the dotted comparison lines
within Fig. 1) would suggest maternal-fetal interaction
effects. The ﬁndings point to both maternal and maternal-
fetal interactive effects in teratogenic risk.
Seeking to distinguish the effects of the maternal envi-
ronment and maternal genetics from fetal genetic effects,
several researchers examined the teratogenic effects of al-
cohol in embryo cultures using C57BL/6 and DBA/2J
mouse strains (Ogawa et al., in press). The C57BL/6 ani-
mals exhibited statistically signiﬁcant deﬁcits in the heart
and in the caudal neural tube; such deﬁcits were not seen
in the DBA/2J strain. However, the DBA/2J embryos ex-
hibited deﬁcits related to branchial bars and somites not
seen in the C57BL/6 embryos. Such deﬁcits could only be
attributed to genetic factors within the fetus.
POLYMORPHISMS OF THE GENES OF
ALCOHOL-METABOLIZING ENZYMES
A number of promising leads in understanding the ge-
netic contributions to fetal alcohol teratogenesis in humans
are derived from studies of the polymorphisms of the
enzymes responsible for the elimination of alcohol from
the body. As shown in Figure 2, the major pathway of
alcohol elimination is its oxidation to acetaldehyde and its
further oxidation to acetate in the liver. The principal en-
zyme catalyzing ethanol oxidation to acetaldehyde is alco-
hol dehydrogenase, ADH, which, in turn, is oxidized to
acetate by the enzyme aldehyde dehydrogenase, ALDH
(Bosron and Li, 1987; Hurley, et al., 2002). The kinetic
properties of the mitochondrial form of ALDH (ALDH2),
as compared with those of the cytosolic form (ALDH1),
indicate that it is responsible for oxidizing the majority of
the acetaldehyde in the body (Hurley et al., 2002).
The equilibrium constant for ADH lies strongly in the
direction favoring the reduction of acetaldehyde to etha-
nol. It is the virtually irreversible oxidation of acetaldehyde
to acetate that drives the oxidation of alcohol (Bosron and
Li, 1987). As a consequence of these kinetic characteristics,
acetaldehyde is normally found within the body at far
lower concentrations than either ethanol or acetate. When
Table 2
ADH1B and ADH1C Polymorphisms*
Nomenclature Amino acid
differences
Enzyme
subunit
Km for EtOH
(mM)
Turnover rate
(min1)New Old
ADH1B*1 ADH2*1 Arg47, Arg369 1 0.05 4
ADH1B*2 ADH2*2 His47, Arg369 2 0.9 350
ADH1B*3 ADH2*3 Arg47, Cys369 3 40.0 300
ADH1C*1 ADH3*1 Arg271, Ile349 1 1.0 90
ADH1C*2 ADH3*2 Gln271, Val349 2 0.6 40
*Hurley et al., (2002); Human Genome Organization Gene Nomenclature Committee (2001).
Figure 1. Maternal effect shown in a diallelic cross (Gilliam et al.,
1997). Dams were intragastrically intubated with 5.8 gm/kg of
ethanol on day 9 of pregnancy. B6 are the ethanol-susceptible
C57BL/6J mice and SS are the ethanol-resistant Short Sleep mice;
(%) refers to the percentage of malformations in ethanol-exposed
fetuses. (Control animals wer given maltose-dextrin and had 4%
fetal abnormalities.)
Figure 2. Alcohol metabolism.
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beverage alcohol is ingested, blood alcohol levels are in the
millimolar range (two drinks may result in a BAC of ap-
proximately 10 mM). Acetaldehyde levels are typically in
the micromolar range, while acetate is also at millimolar
levels in the circulation.
Several distinct classes of human alcohol dehydrogenase
exist (Table 2); however, the majority of ethanol (from
beverage alcohol) is metabolized by isozymes encoded by
three members of the ADH class I family: ADH1A, ADH1B,
and ADH1C1 and by the class II enzyme encoded by ADH4
(Hurley et al., 2002). Further, three functionally distinct
polymorphisms exist for ADH1B and two for ADH1C (Ta-
ble 2), with different binding afﬁnity (Km) for alcohol and
maximal velocities (turnover rates). It has been estimated
that, for an individual expressing the ADH1B*1 and
ADH1C*1 alleles, the isozyme encoded by ADH1C*1 ac-
counts for approximately 40% of the ethanol concentration
at a blood alcohol concentration of 0.10 gm percent (22 mM
ethanol), while those encoded by ADH4 and ADH1B*1
account for approximately 29 and 22%, respectively (Hur-
ley et al., 2002).
As seen in Table 2, the isozyme encoded by ADH1B*2
has a turnover rate over 80 times greater than the isozyme
encoded by ADH1B*1, with a Km indicative of near satu-
ration at 22 mM ethanol. Consequently, the presence of an
ADH1B*2 allele should result in an increase in the rate of
ethanol oxidation. For individuals with the ADH1B*3 al-
lele, the rate of alcohol oxidation should be greater as well
than for individuals with only the ADH1B*1 allele, given
the kinetic characteristics (Km, turnover rate) of the
isozyme encoded by ADH1B*3. As shown in Table 3, more
rapid oxidation of ethanol has been found in individuals
with ADH1B*2 at a BAC level maintained by infusion of
0.05 gm/dl (Neumark et al., 2004) and, in individuals with
ADH1B*3, with an oral dose designed to produce a BAC of
0.08 gm/dl (Thomasson et al., 1995).
The prevalence of the ADH1B allele differs across ethnic
groups, as shown in Table 4. While ADH1B*1 predomi-
nates among white European and American populations,
the ADH1B*2 has an allele frequency of greater than 60%
among individuals of Chinese, Japanese, and Korean eth-
nic background (Thomasson et al., 1991). The ADH1B*2
allele is also present at higher frequency in populations of
American and Israeli Jewish ancestry (Neumark et al.,
1998; Shea et al., 2001). The ADH1B*3 allele has been found
to occur at an allele frequency of approximately 22% in
African-American populations (Thomasson et al., 1995).
In addition, ALDH2*2, which encodes a low activity
variant of the mitochondrial ALDH, occurs with allele
frequency of approximately 30% among Asian populations
(Table 4) (Thomasson et al., 1991). Individuals possessing
ADH1B*2, and/or ALDH2*2 have been found to be less
likely to develop alcohol dependence. This has now been
demonstrated in numerous studies. As shown in Table 5,
Han Chinese males in Taiwan with alcohol dependence
had statistically signiﬁcant lower allele frequencies for
ADH1B*2 and ALDH2*2 than controls (Thomasson et al.,
1991).
Therefore, both ADH1B*2 and ALDH2*2 have been dem-
onstrated to be protective against the development of al-
cohol dependence in Asian populations. A plausible expla-
nation is that the presence of ALDH2*2 results in elevated
levels of acetaldehyde following alcohol consumption
(Shen et al., 1997). The increased acetaldehyde causes an
unpleasant physiological state that serves to discourage
drinking, thereby conferring protection against alcohol de-
pendence. Based upon the same putative mechanism, it
has been hypothesized that ADH1B*2 and ADH1B*3, both
of which encode isozymes that oxidize ethanol at a faster
1The nomenclature for ADH1A, ADH1B, and ADH1C enzymes was recently
changed from ADH1, ADH2, and ADH3, respectively (Human Genome Orga-
nization Gene Nomenclature Committee, 2001).
Table 3
Inﬂuence on Alcohol Metabolism:
ADH1B*2 and ADH1B*3*
ADH1B
genotype (n)a
AER
(gm/hr)
ADH1B
genotype (n)b
60
(mg/dl/hr)
ADH1B*1/*1 (73) 7.1  1.5 ADH1B*1/*1 (50) 11.3  0.2
ADH1B*1/*2 (30) 8.0  1.3c ADH1B*1/*3 (50) 13.1  0.3d
ADH1B*2/*2 (5) 8.7  2.0c ADH1B*3/*3 (12) 13.1  0.6d
*Neumark et al. (2004); Thomasson et al. (1995).
aAlcohol elimination rates (AER) determined from an IV alcohol
clamp session in 109 healthy Israeli Jewish men.
bAlcohol disappearance rates determined following oral alcohol
administration to 112 healthy African-American men and women.
cSigniﬁcantly different from ADH1B*1/*1 group (Neumark et al.,
2004).
dSigniﬁcantly different from ADH1B*1/*1 group (Thomasson et
al., 1995).
Table 4
ADH1B and ALDH2: Ethnic Differences*
ADH1B*1 ADH1B*2 ADH1B*3 ALDH2*1 ALDH2*2
White (European and American) 95% 5% 5% 100% 0%
Jewish (Israeli and American) 80% 20% 5% 100% 0%
African American 85% 5% 22% 100% 0%
Asian (Chinese, Japanese, and Korean) 35% 65% 5% 70% 30%
*Neumark et al. (1998); Thomasson et al. (1991); Thomasson et al. (1995).
Table 5
Protection against Alcohol Dependence
by ADH1B*2 and ALDH2*2*
Han Chinese males in Taiwan
ADH1B*2 ALDH2*2
Nonalcoholic (n  50) 0.73 0.30
Alcoholic (n  50) 0.48a 0.06a
*Thomasson et al. (1991).
ap  0.001.
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rate than the isozyme encoded by ADH1B*1 at higher
ethanol concentrations, may prove protective against alco-
hol-induced teratogenesis, including the development of
FAS. Research exploring the role of the ADH variants in
teratogenesis is presented below. It would also be expected
that ALDH2*2 should be protective for teratogenesis; how-
ever, studies to date of ALDH polymorphisms and fetal
outcome have not been conducted in Asian populations
where ALDH2*2 is found.
ALCOHOL DEHYDROGENASE
POLYMORPHISMS AND TERATOGENESIS
Several reports have appeared on the relationship of
ADH1B polymorphisms and alcohol teratogenic risk. A
study of individuals from the mixed ancestry population in
the Western Cape Province of South Africa examined poly-
morphisms of ADH1B and the occurrence of FAS (Viljoen
et al., 2001). In this population, a prevalence of 46 FAS
cases per 1000 births has been reported (May et al., 2000),
one of the highest rates so far observed anywhere in the
world. The high FAS rate likely derives from a high inci-
dence of heavy drinking among both men and women in
this population. The heavy drinking may be a vestige of
the “dop” system, by which part of an individual’s wages
was provided in the form of wine (London, 1999). Al-
though discouraged and outlawed for many years now, a
long history of the dop system likely contributed to the
development of a heavy-drinking culture.
Within this mixed ancestry population, Viljoen et al.
(2001) examined the allele frequency of ADH1B in FAS
children and their mothers, as well as in a large group of
controls (Table 6). The ADH1B*2 allele frequency for both
the FAS children and their mothers was lower in a statis-
tically signiﬁcant manner than in the controls.2 No statis-
tically signiﬁcant difference was found for the ADH1B*3
allele; however, this allele was present in only a small
percentage of the overall population, which limited the
ability to detect an effect from the allele. The ﬁndings from
the study support a protective role of the ADH1B*2 allele
within either the mother or the fetus. The ﬁndings are
consistent with the hypothesis that the more kinetically
active variant of ADH would provide protection, perhaps
through elevation of acetaldehyde levels resulting in re-
duced maternal alcohol consumption. Alternatively, there
might be an actual gene of inﬂuence in linkage disequilib-
rium with ADH1B, yet to be discovered.
An observational study (Khaole et al., 2004) further ex-
amined the relationship of drinking, alcohol metabolic
rate, and risk for an FAS birth outcome in this mixed
ancestry population. The investigators monitored free-
choice drinking and consequent breath alcohol concentra-
tions (BrACs) among drinking women who previously had
given birth to a child with FAS and drinking women
whose children did not have FAS (Table 7). In this obser-
vational study, the women drank in their own home envi-
ronment with alcohol levels determined by breathalyzer
taken at various time points throughout the session. None
of the women were pregnant at the time of the study, and
2The presence of the ADH1B*2 allele may derive from Malay genetic contri-
butions to the mixed ancestry population.
Table 6
ADH1B Allele Frequencies in Mixed Ancestry Population from Western
Cape Province, South Africa*
Allele frequencies
Number
Allele
number ADH1B*1 ADH1B*2 ADH1B*3
FAS children 56 112 0.928 0.036a 0.036
Mothers of FAS
children 56 112 0.928 0.036a 0.036
Controls 178 356 0.854 0.107 0.039
*Adapted from Viljoen et al. (2001).
aAllele frequencies were signiﬁcantly lower than in controls (p  0.025  0.004).
Table 7
Observational Study: Free-Choice Drinking and BrAC in a
South African Population*
FAS Mothers (n  10)
Non-FAS Mothers
(n  20)
Mean  SE Range Mean  SE Range
Total body weight (kg) 46.2 2.2 33–56 55.9 2.7 42–84
Dose (g of ethanol) 54.3  3.8 40.8–66.0 42.8  1.8 27.2–68.0
Peak breath alcohol
concentration [BrAC] (mg%) 125 8 82–161 92 5 51–139
-60 (mg% per hr) 21.4 1.3 16.4–30.7 20.8 0.8 13.7–28.6
Alcohol elimination rate [AER]
(g per hr) 5.5  0.2 4.5–6.6 6.0  0.3 3.8–8.6
*Khaole et al. (2004).
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a limitation was imposed such that, even though this was
a free-choice drinking study, participants were not permit-
ted to continue drinking if they had attained a BrAC above
150 mg/dl.
As noted in Table 7, alcohol elimination rates did not
differ between the two groups of women. However,
women who had previously given birth to a child with
FAS were smaller in body weight and drank more alcohol
in a free-choice situation, thereby attaining higher peak
BrAC concentrations. This result suggests the hypothesis
that women who give birth to FAS children attain higher
blood alcohol levels when they drink as compared with
women who drink but do not give birth to FAS children.
Another important consideration is the nutritional status of
the mothers who gave birth to FAS children, with under-
nutrition being a contributing factor.
Three studies within the United States have examined
the effect of ADH1B polymorphisms on alcohol-exposed
fetal outcomes (summarized in Table 8). As the prevalence
of FAS in the U.S. population, approximately 1 case/1000
births (Stratton et al., 1996), is much lower than that among
the mixed ancestry population of South Africa (May et al.,
2000), the U.S. studies have assessed a broader range of
outcomes consistent with FASD, including growth, cranio-
facial and neurodevelopmental measures. As the U.S. stud-
ies have predominantly included individuals of African-
American heritage, the ADH1B alleles studied have been
ADH1B*1 and ADH1B*3, and not ADH1B*2, as found in
the South African study.
McCarver et al. (1997) noted that the presence of at least
one copy of maternal ADH1B*3 allele was found to be
protective for two speciﬁc outcomes: reductions in the
infants’ birth weight and birth length, and lower scores on
the Bayley Mental Development Index (MDI) at 12 months
of age (n  243). The presence of at least one copy of the
ADH1B*3 allele in the child was also found to be protective
from lower scores on the MDI. In a recent report, Das et al.
(2004) extended this study by examining measures of facial
morphology from photographs taken at one year of age. A
total of 70% of the 247 children in the photographic anal-
ysis had also been subjects in the study of birth parameters
and Bayley MDI. The authors found that a report of alcohol
use in pregnancy prior to the ﬁrst prenatal visit was asso-
ciated with a statistically signiﬁcant reduction in three
morphometric measures—palpebral ﬁssure length, inner
canthal distance, and nasal bridge to mouth length—when
neither the mother or the infant possessed an ADH1B*3
allele.
In both studies, women were recruited during preg-
nancy and selected on the basis of both drinking status and
genotype. Consequently, because ADH genotype was one
of the selection factors, the allele frequencies for the
ADH1B variants could not be determined.
In a prospective study of alcohol use during pregnancy
(Croxford et al., 2003; Jacobson et al., 2000), 155 mothers
and 185 children were genotyped. All of the children were
studied at birth for intrauterine growth and at 6.5 months,
12 and 13 months, and 7.5 years for various neurodevel-
opmental measures. The analysis indicated an inverse re-
lationship between maternal ADH1B*3 and deﬁcits on a
wide spectrum of birth parameters and physical and neu-
rodevelopmental measures, including: birth weight, head
circumference, Bayley MDI score, cross-modal transfer,
processing speed, novelty preference, elicited play, magni-
tude estimation, attention verbal ﬂuency, and many other
neurodevelopmental parameters. These differences were
found to be related to maternal genotype and no statistical
differences were found based upon child genotype. The
ﬁndings were, therefore, consistent with those of the Mc-
Carver et al. (1997) study for maternal genotype. The sta-
tistically signiﬁcant association found in the McCarver et
al. (1997) study for absence of a fetal ADH1B*3 allele and
the Bayley MDI was not found by Croxford et al. (2003).
In the third study, Stoler et al. (2002) reported on the
ADH1B genotype and fetal outcome in 404 women, 108 of
whom were African-American. The investigators obtained
drinking data for the four-week period prior to the gesta-
tional interview. The number of women who reported
drinking during this interval was small. Only 10 of the 108
African-American women reported drinking 1 drink per
day or greater, and 80 were abstinent. Among the 223
white women, only 3 reported drinking 1 drink per day or
greater and 134 were abstinent. However, the ADH1B*3
allele was present in only 4 (2%) of the white women but in
Table 8
Comparison of Studies on ADH1B*3 in African Americans
Detroita Detroitb Bostonc
Outcomes examined
Allele frequency of
ADH1B*3 d 0.20 0.23
Age at assessment 1 year Up to 7.5 years Neonate
Birth growth measures   
Bayley MDI   —
Extensive neurodevelopment
measures —  —
Facial morphology  — 
Effect of ADH1B*3 genotype
Effect of maternal ADH1B*3 2Risk 2Risk 1Riske
Effect of fetal ADH1B*3 2Risk Not statistically signiﬁcant 1Riske
aMcCarver et al. (1997) and Das et al. (2004).
bCroxford et al. (2003) and Jacobson et al. (2000).
cStoler et al. (2002).
dOversampled.
eIndependent of alcohol exposure.
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50 (46%) of the African-American women. Infant assess-
ment was limited to the neonatal period, a factor that
posed further limitations on detecting an effect of prenatal
alcohol (Chambers and Jones, 2002). Stoler et al. (2002)
characterized infants as “affected” if, as neonates, the sub-
ject exhibited 4 of 6 facial features common in FAS, and/or
growth deﬁcits greater than 2 SD below the mean. The
authors found that 60% (9/15) of the African-American
infants who were “affected” had an ADH1B*3 allele, com-
pared with 29% (8/28) of the unaffected infants. This ﬁnd-
ing was statistically signiﬁcant at the level of p  0.045.
Maternal genotype correlated with alcohol-related physi-
cal features in the child, at an odds ratio (OR) of 2.49
(conﬁdence interval  95%, 0.809–7.66). However, alcohol
exposure was not signiﬁcantly associated with infant out-
come, after accounting for genotype, smoking, and mater-
nal weight gain.
The results of this study differed from those of both
McCarver et al. (1997) and Croxford et al. (2003), in that the
absence of the ADH1B*3 allele was protective for fetal
outcome, whereas the other two studies found that the
presence of the ADH1B*3 allele was protective. A number
of factors may underlie the differences in these ﬁndings.
McCarver et al. (1997) followed a cohort throughout in-
fancy and obtained Bayley MDI measures at 12 months of
age. Croxford et al. (2003) reported on neurodevelopmen-
tal measures at multiple developmental points up to age
7.5 years. Stoler et al. (2002) limited their observations to
the neonatal period. Additionally, few women in the study
by Stoler et al. (2002) reported drinking during pregnancy.
In summary, ADH1B variants have been found to be
associated with risk or protection from fetal-alcohol injury,
with ADH1B*2 being protective for FAS in the South-
African mixed ancestry population. Replication of the as-
sociation of ADH1B*2 with lower FAS(D) outcome is
needed. Two of three studies in African-American women
showed ADH1B*3 to be potentially protective for growth
and neurodevelopmental teratogenesis.
While the presence of either ADH1B*2 or ADH1B*3 vari-
ants appears to afford protection from alcohol-derived ter-
atogenesis, the mechanism by which this protection is at-
tained has not been established. It is possible that
protection may derive from an association of the allele
with differences in alcohol pharmacokinetics, or to differ-
ences in the quantity, frequency, or pattern of alcohol
consumption. Ingesting a given amount of alcohol over a
shorter time interval will result in a higher BAC and pose
a greater risk for the fetus (Maier and West, 2001). Studies
on pregnancy outcome and ADH1B allele type, to date,
have provided limited data on the pattern of consumption.
It is also possible that the ADH1B allele is not directly
involved in the mechanism of protection but rather is in
linkage disequilibrium with another gene conferring pro-
tection (Osier et al., 1999).
It is clear that further studies of the ADH polymor-
phisms, for ADH1B as well as other class I ADH enzymes,
are warranted.
OTHER POLYMORPHISMS
Many other genes are likely to underlie risk or protection
from alcohol teratogenic injury. One particular candidate
gene that warrants assessment is the long allele promoter
of the serotonin transporter gene (5-HTTLPR). This variant
of the promoter appears to be responsible for increased
serotonin reuptake activity, thereby reducing serotonin
levels within the synapse. In several recent reports (Narita
et al., 2001; Weese-Mayer et al., 2003), 5-HTTLPR has been
found to correlate positively with the risk for sudden in-
fant death syndrome (SIDS) in Japanese and U.S. Cauca-
sian/African-American populations. In a recent epidemi-
ologic study, alcohol was shown to be a signiﬁcant risk
factor for SIDS (Iyasu et al., 2002). The adjusted OR for
SIDS was 6.2 with any periconceptual drinking and 8.2
with ﬁrst trimester binge drinking (equal to or greater than
ﬁve drinks on one occasion). Serotonin mechanisms have
also been found to be an important factor in alcohol-
teratogenic risk (Zhou et al., 2003), with alcohol affecting
the timely development of midline neural tissue during
neural tube formation. Hence, it is plausible that serotonin
and the serotonin transporter may be a common mecha-
nism that underlies both SIDS and alcohol teratogenesis.
FUTURE GENETIC STUDIES
Identiﬁcation of the many genetic factors that contribute
to the risk for FAS and alcohol teratogenesis will depend
upon future investigations employing more advanced in-
vestigative designs. There are several alternative designs,
each having its own strengths and limitations (Riley et al.,
2003).
A case-control study is the easiest to implement and this
design has been used in FAS genetic studies to date (e.g.,
Viljoen et al., 2001). The case is either an individual with
FAS or an individual with some degree of FASD, if the full
range of FASD outcomes is followed. The control is an
unaffected, unrelated individual. A limitation of case-con-
trol association studies is the potential for erroneous false-
positive associations arising from population stratiﬁcation.
However, some genomic control methods are being devel-
oped to attempt to address this problem (Rosenberg et al.,
2003). Other potential problems can arise if there is poor
matching of the cases and controls. In FAS genetic re-
search, it would be desirable to match for ethnicity and for
as many maternal factors as are feasible (Riley et al., 2003).
While case-control studies on FAS risk to date have
employed only a single control group, having two control
groups would increase the power of a study. One of these
control groups would be unaffected children of mothers
who drank during pregnancy, while the other would be
mothers who did not drink and, therefore, were not at risk
for giving birth to a child with any alcohol teratogenesis.
An alternative study model involves testing for associa-
tions within a family, for example, through use of an
analysis method known as the transmission disequilibrium
test (TDT). In this approach, phenotypic and genotypic
information is collected from an affected individual and
genotypic information from the parents. The method is
most commonly used to test a candidate gene. A limitation
of this model includes the need to have genotypic infor-
mation on both parents. Therefore, this approach may be
appropriately employed only in areas where children with
FAS are likely to be living with their biological parents.
This is not frequently the case for FAS populations within
the United States, but is much more common in other
countries such as South Africa. Even if both parents are
available, a further requirement is that at least one parent
be heterozygous for the gene of interest. An extension of
the TDT design that may be useful is an approach that tests
discordant siblings, called the sib-TDT. In this approach,
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the genotypes from unaffected siblings can be used, when
genotypic information from one parent is missing.
Family linkage is a powerful design for identifying
genes contributing to genetic disease. The experimental
approach involves the recruitment of families having mul-
tiple individuals with the trait of interest. The DNA from
the family members is then subjected to a genome screen
employing microsatellite or single nucleotide polymor-
phism markers in order to detect linkage. One limitation of
this approach is that testing requires specifying a disease
inheritance model. In alcohol and pregnancy research, the
major concern with the family linkage approach is the
ability to identify enough families to have the power to
detect linkage. Also, the inheritance model for FAS is still
unknown. However, if a sufﬁcient number of families were
found, as in a population with very high alcohol exposure
and FAS rates, analyses could be performed to detect link-
age for maternal susceptibility to have children with FAS,
or susceptibility genes of the fetus.
Regardless of the study design employed, there are sev-
eral measurement issues that will prove essential for
achieving meaningful results. First is the requirement for
comprehensive understanding of the level and pattern of
alcohol exposure preceding and during pregnancy. Infor-
mation is required on the quantity of alcohol consumed,
the time period over which it is consumed, and the fre-
quency of drinking occasions. Knowledge of when in ges-
tation alcohol consumption occurred is also of considerable
value. Next, the phenotype must be adequately described;
this is particularly important in comparisons across differ-
ent studies. Phenotypic deﬁnitions have differed among
studies. For example, while some investigators have de-
ﬁned growth restriction in FAS as birth, length, or head
circumference below the 10th percentile, others have im-
posed a criterion of the 3rd percentile (2 SD). Other dis-
tinctions in previous studies have been made with respect
to the importance of speciﬁc facial features such as small
palpebral ﬁssures, an elongated and hypoplastic philtrum,
and the thickness of the vermillion lip border. With respect
to facial features, the development of technology such as
three-dimensional cameras may help in the measurement
and deﬁnition of physical parameters in future research
studies. Two reports have recently appeared that attempt
to standardize the phenotypic description of FAS (Bertrand
et al., 2004; Hoyme et al., 2005). These should help in
assuring compatibility of future research studies.
Recently, the ﬁeld of ecogenetics has emerged from the
discipline of pharmacogenetics. Ecogenetics investigates
how genetic polymorphisms may represent risk factors for
a number of diseases associated with exposure to environ-
mental substances (Costa, 2000). The study of alcohol ter-
atogenesis would appear to ﬁt appropriately as an area of
investigation within ecogenetics.
SUMMARY
Our knowledge of the genetic factors that underlie vul-
nerability for FAS and alcohol teratogenesis is at an early
stage of development. Animal research and human epide-
miologic studies on alcohol and pregnancy have shown
that both maternal and fetal genetic factors may contribute
to alcohol teratogenic risk. In epidemiological research,
polymorphisms of a gene in alcohol metabolism, ADH1B,
have been found to contribute to the risk for FAS and other
alcohol-related fetal outcomes. Clearly there are many
other genes that will be found to contribute to vulnerabil-
ity. By its very nature, alcohol teratogenesis is the expres-
sion of the interaction of genes and environment. Besides
alcohol, there are other maternal factors, such as nutrition,
and intrauterine environmental factors, that will likely con-
tribute to fetal teratogenesis. These potential risk factors
need further investigation. The study of the interaction of
these environmental factors with genetics should lead to
greater understanding of FASD, including FAS, and afford
us a better understand of how these birth defects may be
prevented.
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